Product Information

MIDODRINE HCL 5 MG TABLET is a generic product labeled by McKesson, priced at $0.1084 per EA under NDC 63739014510. Its NADAC has been published 160 times since Feb 8, 2023.

FDA first approved this application on Oct 1, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the midodrine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MIDODRINE HCL 5 MG TABLET

midodrine hydrochloride
$0.1084per EA
Discontinued
High Outlier

Strength

5 mg/1

Manufacturer

McKesson

NDC

63739014510

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

2/18/2026

Active Ingredients

MIDODRINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207849

FDA Approved

10/1/2020

TE Code

AB

On Market Since

10/15/2020

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for MIDODRINE HCL 5 MG TABLET has been published 160 times since Feb 8, 2023, and over the history we have for it it has declined 47.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1084 per EA
All-time high$0.2595 (Jun 14, 2023)
All-time low$0.1084 (Feb 18, 2026)
52-week high$0.1138
52-week low$0.1084
Median price$0.1486
Average price$0.1603
Largest weekly change+38.5% (Aug 21, 2024)
Weeks tracked160
Tracking sinceFeb 8, 2023

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-4.7%

3Y

-32.7%

5Y

N/A

All

-47.7%

Last surveyed Feb 25, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MIDODRINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MIDODRINE HCL 5 MG TABLET, manufactured by McKesson, is $0.1084 per EA (NDC 63739014510), effective Feb 25, 2026.

How has the price of MIDODRINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MIDODRINE HCL 5 MG TABLET has declined 47.7%. It has been tracked across 160 weekly CMS publications since Feb 8, 2023.

What are the highest and lowest recorded NADAC prices for MIDODRINE HCL 5 MG TABLET?

Since Feb 8, 2023, the NADAC for MIDODRINE HCL 5 MG TABLET has ranged from a low of $0.1084 (Feb 18, 2026) to a high of $0.2595 (Jun 14, 2023), with a median of $0.1486 per EA.

Are there cheaper alternatives to MIDODRINE HCL 5 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MIDODRINE HCL 5 MG TABLET, is $0.1035 per EA — about 5% below MIDODRINE HCL 5 MG TABLET.

Who manufactures MIDODRINE HCL 5 MG TABLET?

MIDODRINE HCL 5 MG TABLET (NDC 63739014510) is labeled by McKesson, and CMS classifies it as a generic product.